Pre-and post-operative risk factors associated with cerebrovascular accidents in patients supported by left ventricular assist device-single center's experience in Japan

Circulation Journal

Volumn 75, Issue 5, 2011, Pages 1138-1146

  Nakajima, Ikutaro ^a   Kato, Tomoko S ^a   Komamura, Kazuo ^a   Takahashi, Ayako ^a   Oda, Noboru ^b   Sasaoka, Taro ^c   Asakura, Masanori ^a,c   Hashimura, Kazuhiko ^d   Kitakaze, Masafumi ^a  

^a Department of Cardiovascular Medicine ^*  (Japan)

^b HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d Yao Municipal Hospital   (Japan)

Author keywords

Cerebrovascular accident; Heart failure; Risk factor; Ventricular assist device

Indexed keywords

BILIRUBIN; C REACTIVE PROTEIN;

ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD CULTURE; CARDIOGENIC SHOCK; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; FEMALE; HEART ASSIST DEVICE; HEART DISEASE; HEART FAILURE; HEART HEMODYNAMICS; HEART INDEX; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART TRANSPLANTATION; HIGH RISK PATIENT; HUMAN; ISCHEMIC HEART DISEASE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MEAN ARTERIAL PRESSURE; MYOCARDITIS; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; RETROSPECTIVE STUDY; RISK FACTOR;

HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; INFECTION; JAPAN; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROSTHESIS IMPLANTATION; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE;

EID: 79955695934     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-0986     Document Type: Article

References (25)

1. Taylor DO, Edwards LB, Boucek MM, Trulock EP, Aurora P, Christie J, et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-fourth official adult heart transplant report-2007. J Heart Lung Transplant 2007; 26: 769-781.
2. Jaski BE, Kim JC, Naftel DC, Jarcho J, Costanzo MR, Eisen HJ, et al; Cardiac Transplant Research Database Research Group. Cardiac transplant outcome of patients supported on left ventricular assist device vs. intravenous inotropic therapy. J Heart Lung Transplant 2001; 20: 449-456.
3. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, et al; Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 2001; 345: 1435-1443.
4. Rose EA, Moskowitz AJ, Packer M, Sollano JA, Williams DL, Tierney AR, et al. The REMATCH trial: Rationale, design, and end points: Randomized evaluation of mechanical assistance for thetreatment of congestive heart failure. Ann Thorac Surg 1999; 67: 723-730.
5. Holman WL, Kormos RL, Naftel DC, Miller MA, Pagani FD, Blume E, et al. Predictors of death and transplant in patients with a mechanical circulatory support device: A multi-institutional study. J Heart Lung Transplant 2009; 28: 44-50.
6. Saito S, Matsumiya G, Sakaguchi T, Miyagawa S, Yoshikawa Y, Yamauchi T, et al. Risk factor analysis of long-term support with left ventricular assist system. Circ J 2010; 74: 715-722.
7. Osada K, Imaizumi T; Heart Transplant Candidate Registry Committee of the Japanese Circulation Society. Special report from the heart transplant candidate registry committee in Japan. J Heart Lung Transplant 2005; 24: 810-814.
8. Saito S, Nishinaka T, Yamazaki K. Long-term circulatory support with a left ventricular assist device therapy in Japan. Circ J 2010; 74: 624-625.
9. Frazier OH, Rose EA, Oz MC, Dembitsky W, McCarthy P, Radovancevic B, et al. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg 2001; 122: 1186-1195.
10. Portner PM, Jansen PG, Oyer PE, Wheeldon DR, Ramasamy N. Improved outcomes with an implantable left ventricular assist system: A multicenter study. Ann Thorac Surg 2001; 71: 205-209.
11. Takahashi A, Kato TS, Oda N, Komamura K, Asakura M, Hashimura K, et al. Prothrombin complex concentrate for rapid reversal of warfarin-induced anticoagulation in patients with intracerebral hemorrhages supported by Left Ventricular Assist Device. Int J Gerontol 2010; 4: 143-147.
12. Sasaoka T, Kato TS, Komamura K, Takahashi A, Nakajima I, Oda N, et al. Improved long-term performance of pulsatile extracorporeal left ventricular assist device. J Cardiol 2010; 56: 220-228.
13. Kirklin JK, Naftel DC, Stevenson LW, Kormos RL, Pagani FD, Miller MA, et al. INTERMACS database for durable devices for circulatory support: First annual report. J Heart Lung Transplant 2008; 27: 1065-1072.
14. Fukushima N, Ono M, Nakatani T, Minami M, Konaka S, Ashikari J. Strategies for maximizing heart and lung transplantation opportunities in Japan. Transplantation Proc 2009; 41: 273-276.
15. Oda N, Kato TS, Komamura K, Hanatani A, Mano A, Hashimura K, et al. Clinical course and outcome of heart transplant recipients; single center's experience at National Cardiovascular Center in Japan. Int Heart J 2010; 51: 264-271.
16. Alba AC, Rao V, Ivanov J, Ross HJ, Delgado DH. Usefulness of the INTERMACS scale to predict outcomes after mechanical assist device implantation. J Heart Lung Transplant 2009; 28: 827-833.
17. Chiesa C, Pellegrini G, Panero A, Osborn JF, Signore F, Assumma M, et al. C-reactive protein, interleukin-6, and procalcitonin in the immediate postnatal period: Influence of illness severity, risk status, antenatal and perinatal complications, and infection. Clin Chem 2003; 49: 60-68.
18. Schots R, Kaufman L, Van Riet I, Lacor P, Trullemans F, De Waele M, et al. Monitoring of C-reactive protein after allogeneic bone marrow transplantation identifies patients at risk of severe transplantrelated complications and mortality. Bone Marrow Transplant 1998; 22: 79-85.
19. Syrjänen J. Infection as a risk factor for cerebral infarction. Eur Heart J 1993; 14(Suppl K): 17-19.
20. Kannoth S, Iyer R, Thomas SV, Furtado SV, Rajesh BJ, Kesavadas C, et al. Intracranial infectious aneurysm: Presentation, management and outcome. J Neurol Sci 2007; 256: 3-9.
21. Kavarana MN, Pessin-Minsley MS, Urtecho J, Catanese KA, Flannery M, Oz MC, et al. Right ventricular dysfunction and organ failure in left ventricular assist device recipients: A continuing problem. Ann Thorac Surg 2002; 73: 745-750.
22. Aaronson KD, Schwartz JS, Chen TM, Wong KL, Goin JE, Mancini DM. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 1997; 95: 2660-2667.
23. Ommen SR, Hodge DO, Rodeheffer RJ, McGregor CG, Thomson SP, Gibbons RJ. Predictive power of the relative lymphocyte concentration in patients with advanced heart failure. Circulation 1998; 97: 19-22.
24. Rogers JG, Aaronson KD, Boyle AJ, Russell SD, Milano CA, Pagani FD, et al; HeartMate II Investigators. Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. J Am Coll Cardiol 2010; 55: 1826-1834.
25. Lietz K. Destination therapy: Patient selection and current outcomes. J Card Surg 2010; 25: 462-471.